Literature DB >> 1419599

Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge).

F Okada1, M Hosokawa, J I Hamada, J Hasegawa, M Kato, M Mizutani, J Ren, N Takeichi, H Kobayashi.   

Abstract

The QR regressor tumour (QR-32), a fibrosarcoma which is unable to grow progressively in normal syngeneic C57BL/6 mice, was able to grow progressively in 13 out of 22 mice (59%) when it was subcutaneously coimplanted with gelatin sponge. We established four culture tumour lines from the resultant tumours (QRsP tumour lines). These QRsP tumour lines were able to grow progressively in mice even in the absence of gelatin sponge. The ability of QRsP tumour cells to colonise the lungs after intravenous injection and to produce high amounts of prostaglandin E2 (PGE2) during in vitro cell culture was much greater than that of parent QR-32 cells. These biological characteristics of QR-32 cells and QRsP tumour cells were found to be stable for at least 6 months when they were maintained in culture. We also observed that QR-32 cells were able to grow progressively in five out of 12 (42%) mice after coimplantation with plastic non-adherent peritoneal cells obtained from mice which had been intraperitoneally implanted with gelatin sponge. These host cells reactive to gelatin sponge increased the production of high amounts of PGE2 by QR-32 cells during 48 h coculture. Preliminary in vitro studies implicated the involvement of hydrogen peroxide and hydroxyl radical as some of the factors necessary to induce QR-32 cells to produce high amounts of PGE2 and to accelerate tumour progression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419599      PMCID: PMC1977431          DOI: 10.1038/bjc.1992.329

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge.

Authors:  Y Sasaki; S Imaoka; H Kasugai; M Fujita; S Kawamoto; S Ishiguro; J Kojima; O Ishikawa; H Ohigashi; H Furukawa
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

2.  Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.

Authors:  K Yamashina; B E Miller; G H Heppner
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

3.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.

Authors:  K Morikawa; S M Walker; J M Jessup; I J Fidler
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

4.  Recruitment of unsensitized circulating lymphocytes to sites of allogeneic cellular interactions.

Authors:  D W Hanto; U T Hopt; R Hoffman; R L Simmons
Journal:  Transplantation       Date:  1982-05       Impact factor: 4.939

5.  Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2.

Authors:  F Okada; M Hosokawa; J Hasegawa; M Ishikawa; I Chiba; Y Nakamura; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA 100.

Authors:  A M Fulton; S E Loveless; G H Heppner
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

7.  Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads.

Authors:  C W Boone
Journal:  Science       Date:  1975-04-04       Impact factor: 47.728

8.  "Sontaneous" neoplastic transformation in vitro: a form of foreign body (smooth surface) tumorigenesis.

Authors:  C W Boone; N Takeichi; S D Eaton; M Paranjpe
Journal:  Science       Date:  1979-04-13       Impact factor: 47.728

9.  Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma.

Authors:  M Ishikawa; M Hosokawa; N Oh-hara; Y Niho; H Kobayashi
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

10.  Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine.

Authors:  M Ishikawa; F Okada; J Hamada; M Hosokawa; H Kobayashi
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

View more
  18 in total

1.  The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells.

Authors:  Futoshi Okada; Masanobu Kobayashi; Hiroki Tanaka; Tokushige Kobayashi; Hiroshi Tazawa; Yoshihito Iuchi; Kunishige Onuma; Masuo Hosokawa; Mary C Dinauer; Nicholas H Hunt
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  Calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma.

Authors:  Koji Harada; Takanori Takenawa; Tarannum Ferdous; Yasuhiro Kuramitsu; Yoshiya Ueyama
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

Review 3.  Fibrosarcoma arising from gouty tophi: report of a unique case and review of literature.

Authors:  Jian-Jun Wang; Hai-Yan Wang; Kai Cheng; Xuan Wang; Bo Yu; Shan-Shan Shi; Xiao-Jun Zhou; Qun-Li Shi
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

4.  Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells.

Authors:  Tokushige Kobayashi; Futoshi Okada; Nobuyuki Fujii; Naoko Tomita; Satoru Ito; Hiroshi Tazawa; Tetsuya Aoyama; Sung Ki Choi; Toshiyuki Shibata; Hisakazu Fujita; Masuo Hosokawa
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 5.  Inflammation-related carcinogenesis: current findings in epidemiological trends, causes and mechanisms.

Authors:  Futoshi Okada
Journal:  Yonago Acta Med       Date:  2014-07-30       Impact factor: 1.641

6.  Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression.

Authors:  Hiroshi Tazawa; Futoshi Okada; Tokushige Kobayashi; Mitsuhiro Tada; Yukiko Mori; Yoshie Une; Fujiro Sendo; Masanobu Kobayashi; Masuo Hosokawa
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

7.  Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells.

Authors:  Kunishige Onuma; Yu Sato; Satomi Ogawara; Nobuyuki Shirasawa; Masanobu Kobayashi; Jun Yoshitake; Tetsuhiko Yoshimura; Masaaki Iigo; Junichi Fujii; Futoshi Okada
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

8.  Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells.

Authors:  F Okada; K Nakai; T Kobayashi; T Shibata; S Tagami; Y Kawakami; T Kitazawa; R Kominami; S Yoshimura; K Suzuki; N Taniguchi; O Inanami; M Kuwabara; H Kishida; D Nakae; Y Konishi; T Moriuchi; M Hosokawa
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy.

Authors:  J Hamuro; T Kikuchi; F Takatsuki; M Suzuki
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.

Authors:  F Okada; M Hosokawa; J Hasegawa; Y Kuramitsu; K Nakai; L Yuan; H Lao; H Kobayashi; N Takeichi
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.